CN100410266C - Synthesizing process of podophyllotoxin phosphonate derivate - Google Patents

Synthesizing process of podophyllotoxin phosphonate derivate Download PDF

Info

Publication number
CN100410266C
CN100410266C CNB2006100111495A CN200610011149A CN100410266C CN 100410266 C CN100410266 C CN 100410266C CN B2006100111495 A CNB2006100111495 A CN B2006100111495A CN 200610011149 A CN200610011149 A CN 200610011149A CN 100410266 C CN100410266 C CN 100410266C
Authority
CN
China
Prior art keywords
formula
carbon atoms
alkyl
synthetic method
carbon atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006100111495A
Other languages
Chinese (zh)
Other versions
CN100999534A (en
Inventor
郝光富
胡世权
田凯
李江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Huapont Pharm Co Ltd
Original Assignee
HUABANG PHARMACEUTICAL CO Ltd CHONGQING
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUABANG PHARMACEUTICAL CO Ltd CHONGQING filed Critical HUABANG PHARMACEUTICAL CO Ltd CHONGQING
Priority to CNB2006100111495A priority Critical patent/CN100410266C/en
Publication of CN100999534A publication Critical patent/CN100999534A/en
Application granted granted Critical
Publication of CN100410266C publication Critical patent/CN100410266C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to synthesis process of podophyllotoxin phosphate derivative. In the presence of tetrahalo methane, tertiary amine and 4-dimethylamido pyridine, podophyllotoxin derivative and phosphorous acid derivative are reacted for 1 hr. The present invention has simple operation, low production cost, short reaction period, high product yield and high product purity.

Description

The synthetic method of podophyllotoxin phosphonate derivate
Technical field:
The present invention relates to the synthetic method of podophyllotoxin phosphonate derivate.Be specifically related to podophyllotoxin derivative is carried out a kind of novel method of phosphorylated.
Background technology:
The phosphoric acid ester of podophyllotoxin derivative is the water-soluble antitumor drug of a class, and its structure is suc as formula shown in the I.
The common preparation method of the phosphoric acid ester of podophyllotoxin derivative is that the phenolic hydroxyl group with podophyllotoxin derivative (formula II) obtains after phosphorylated:
Figure C20061001114900041
R in the formula 1And R 2Multiple different substituting group can be arranged, obtain different derivatives.As work as R 1Be methyl, R 2, R 3, R 4When being hydrogen, be antitumor drug phosphoric acid Etoposide; R 1Be the 2-thienyl, R 2, R 3, R 4When being hydrogen, be antitumor drug phosphoric acid teniposide.
Owing in the glycosyl of podophyllotoxin molecule two hydroxyls are arranged, phosphating reaction also easily take place.Therefore, the phenolic hydroxyl group orientation of podophyllotoxin molecule being carried out phosphating reaction acquires a certain degree of difficulty.
English Patent 2207674 has been reported the preparation method of phosphoric acid Etoposide, and it is as Phosphation reagent with diphenyl phosphate chloride that this method is carried out the selectivity Phosphation.A disclosed example is that Etoposide and diphenyl phosphate chloride reaction generate the Etoposide diphenyl phosphate, gets etoposide phosphate through catalytic hydrogenation.This method has two big shortcomings: the one, and long reaction time needs nearly 100 hours; The 2nd, the cost height, the agents useful for same diphenyl phosphate chloride costs an arm and a leg.
The method of Chinese patent CN1189499A (on November 4th, 1993) is the hydroxyl protection of elder generation with glycosyl, carries out Phosphation again.Disclosed preparation method is that 4 '-demethyl table poison mortar toxin and the reacted product of dibenzyl phosphite generate intermediate with protected sugar again under Louis acid catalysis, obtains the phosphoric acid Etoposide through catalytic hydrogenation.This method needs protection sugar earlier, also needs the deprotection base, and complicated operation, preparation cost are also very high.
Summary of the invention:
The purpose of this invention is to provide the novel method that a kind of podophyllotoxin derivative (formula I) carries out phosphorylated, this method technology is simple, the reaction times is shorter, and cost is low than prior art.
Novel method provided by the invention is as described below:
Formula II compound is reacted with phosphorous acid derivative (formula III) in the presence of tetrahalomethanes, tertiary amine and phosphorylated catalyzer 4-dimethylamino pyridine; temperature of reaction is controlled at-10 ℃~-30 ℃; 30~60 minutes reaction times can obtain formula I compound, and reaction formula is as follows:
Figure C20061001114900051
In the formula:
R 1Be selected from the cycloalkyl, 2-furyl, 2-thienyl, the aromatic base of 6~10 carbon atoms, the aralkyl of 7~14 carbon atoms, the aralkenyl of 8~14 carbon atoms of the alkenyl of the alkyl of 1~10 carbon atom, 2~10 carbon atoms, 5~6 carbon atoms, wherein aromatic nucleus can also can have substituting group by unsubstituted, and its substituting group can be selected from substituting groups such as the alkoxyl group, hydroxyl, nitro, amido of the alkyl of halogen atom, 1~8 carbon atom, 1~8 carbon atom;
R 2Be selected from the alkyl of hydrogen or 1~8 carbon atom;
Perhaps, R 1And R 2It is through the carbon atom connection and the cycloalkyl of 5~6 carbon atoms of formation;
X is oxygen or sulphur;
R 3And R 4It is respectively the alkyl of 1~5 carbon atom replacing of the alkyl that is selected from hydrogen, 1~5 carbon atom, halogen, the alkyl of 1~5 carbon atom that cyano group replaces, the cycloalkyl of 3~6 carbon atoms, the aromatic base of 6~10 carbon atoms, the aralkyl of 7~14 carbon atoms, wherein aromatic nucleus can unsubstituted or substituting group is arranged, and its substituting group is selected from alkyl, halogen, nitro; R 3And R 4Can be metallic element also, make formula I compound become salt, be preferably disodium salt, its structure be:
Figure C20061001114900061
Perhaps
Figure C20061001114900062
In above-mentioned reaction:
Reaction solvent can be selected the solubilized reactant and the solvent that can not participate in reacting, as acetonitrile, tetrahydrofuran (THF), ethyl acetate etc.;
Halogen is selected from fluorine, chlorine, bromine, iodine in the described tetrahalomethanes, can be the same or different, and consumption is preferably equivalent;
Described tertiary amine is selected from N, and N-diisopropylethylamine, triethylamine, consumption are preferably 2 equivalents
4-dimethylamino pyridine consumption is preferably 0.2 equivalent.
The consumption of phosphorous acid derivative (formula III) is preferably equivalent.
Method of the present invention has the following advantages:
1. simple to operate
1) do not need protection two hydroxyls on the sugar, one step of reaction carries out, and promptly is oriented in the phenolic hydroxyl group phosphorylated;
2) each reactant once adds and need not add in batches, operates easier;
2. cost is low
Phosphorus esterification reagent is di-substituted with the lower phosphorous acid of price, does not use the more expensive chlorine di(2-ethylhexyl)phosphate substitutive derivative of price, has reduced production cost;
3. shortened the reaction times greatly
Be reflected in 1 hour and finish, and English Patent 2207674 needs nearly 100 hours;
4. product yield height, purity height
Reaction yield is measured purity more than 90% up to 90% through high performance liquid phase form and aspect method.
Embodiment:
React the example that obtains the Etoposide phosphate dibenzyl ester by Etoposide and dibenzyl phosphite below, the present invention is elaborated.Gained Etoposide phosphate dibenzyl ester promptly obtains antitumor drug phosphoric acid Etoposide through hydrogenation.But it should be understood that present embodiment only is used to illustrate method of the present invention, does not limit the present invention.
Synthesizing of embodiment 1 phosphoric acid Etoposide
1) preparation Etoposide phosphate dibenzyl ester
Figure C20061001114900071
Logical nitrogen adds the 30g Etoposide in 1 liter of three mouthfuls of reaction flask, and 600ml analytical pure acetonitrile cools to below-10 ℃ with cold salt bath under stirring, and adds CCl successively 425ml, N, N-diisopropylethylamine 20ml, 4-dimethylamino pyridine 1.2g is dripping the solution that dibenzyl phosphite 35g and 20ml acetonitrile are formed below-10 ℃, add the back-30 ℃ to-10 ℃ react disappear to the raw material Etoposide till, approximately need 1 hour.Reaction is poured reaction solution into 200ml 0.5M KH after finishing 2PO 4In the aqueous solution, with the extraction of 3 * 400ml ethyl ester, rare NaHCO 3Be washed to neutrality, wash with water again, the anhydrous magnesium sulfate drying organic layer, 50 ℃ of water-bath vacuum concentration get crude product 45g to doing, and HPLC surveys content 90%, and is so purified that content can carry out next step reaction after 97%.
2) preparation phosphoric acid Etoposide
Make solvent with methyl alcohol, the Etoposide phosphate dibenzyl ester that preceding step reaction is obtained gets through the hydrogenation of normal temperature pressurized catalysis.The concrete operations step is as follows:
In the autoclave of clean dried, add Etoposide phosphate dibenzyl ester 39 grams after making with extra care, anhydrous methanol 390ml, 10%Pd/C 5g stirs, logical at normal temperatures H 2Pressure 2~20 normal atmosphere carried out hydrogenation 2 to 10 hours, it is complete to detect raw material reaction through high performance liquid chromatography, stop hydrogenation, filter out catalyzer (can reuse), filtrate is concentrated into dried, and with 75 ℃ of hot anhydrous alcohol solution after-filtration, airtight being put in 60 ℃ of hot water baths left standstill slow cool overnight, filter crystal normal temperature P 2O 5Vacuum-drying gets colourless acicular crystal 28g, and greater than 99%, yield is greater than 80% through the HPLC detection level.147 ℃ of flavescence are decomposed.
Reaction formula is:
Figure C20061001114900081
MS(FAB)669.1
1HNMR(DMSO)
1.226(1H,d)2.852~2.923(1H,m)3.048(1H,t)
3.150(1H,dd)3.237(1H,m)3.349~3.293(2H,m)3.430(1H,m)
3.494(1H,t)3.588(6H,s)4.0645(1H,q)4.2265(2H,d)4.548(1H,d)
4.566(1H,d)4.7125(1H,q)4.936(1H,q)5.221(1H,bs)6.016(2H,s)
6.211(2H,s)6.526(1H,s)7.005(1H,s)
13CNMR(DMSO)
174.487?150.853?147.496?145.970?136.297?132.04?128.530?128.363
109.641?109.519?107.49?101.173?101.035?98.365?79.735?73.937?72.305
71.542?67.468?67.041?65.469?55.689?42.765?39.973?36.998?19.970

Claims (8)

1. the synthetic method of compound of Formula I in the presence of tetrahalomethanes, tertiary amine and 4-dimethylamino pyridine, is reacted formula II compound and formula III compound, and temperature of reaction is-10 ℃~-30 ℃, 30~60 minutes reaction times:
Formula II formula III formula I
In the formula:
R 1Be selected from the cycloalkyl, 2-furyl, 2-thienyl, the aromatic base of 6~10 carbon atoms, the aralkyl of 7~14 carbon atoms, the aralkenyl of 8~14 carbon atoms of the alkenyl of the alkyl of 1~10 carbon atom, 2~10 carbon atoms, 5~6 carbon atoms, wherein aromatic nucleus can also can have substituting group by unsubstituted, and its substituting group can be selected from alkyl, the alkoxyl group of 1~8 carbon atom, hydroxyl, nitro, the amido of halogen atom, 1~8 carbon atom;
R 2Be selected from the alkyl of hydrogen or 1~8 carbon atom;
Perhaps, R 1And R 2It is through the carbon atom connection and the cycloalkyl of 5~6 carbon atoms of formation;
X is oxygen or sulphur;
R 3And R 4Be selected from the alkyl of 1~5 carbon atom that the alkyl, halogen of hydrogen, 1~5 carbon atom replace respectively, the alkyl of 1~5 carbon atom that cyano group replaces, the cycloalkyl of 3~6 carbon atoms, the aromatic base of 6~10 carbon atoms, the aralkyl of 7~14 carbon atoms, wherein aromatic nucleus can unsubstituted or substituting group is arranged, and its substituting group is selected from alkyl, halogen, nitro; R 3And R 4It also can be metallic element.
2. the synthetic method of the described compound of Formula I of claim 1, wherein R 1Be methyl or 2-thienyl, R 2Be hydrogen.
3. the synthetic method of the described compound of Formula I of claim 1, wherein R 3And R 4Be respectively hydrogen or benzyl.
4. the synthetic method of the described compound of Formula I of claim 1, wherein R 3And R 4Be respectively sodium.
5. the synthetic method of the described compound of Formula I of claim 1, wherein X is an oxygen.
6. the synthetic method of the described compound of Formula I of claim 1, halogen is selected from fluorine, chlorine, bromine, iodine in the described tetrahalomethanes; Halogen can be the same or different.
7. the synthetic method of the described compound of Formula I of arbitrary claim in the claim 1~6, used reaction solvent is selected from acetonitrile, tetrahydrofuran (THF) or ethyl acetate.
8. the synthetic method of the described compound of Formula I of arbitrary claim in the claim 1~6, described tertiary amine is selected from N, N-diisopropylethylamine, triethylamine.
CNB2006100111495A 2006-01-11 2006-01-11 Synthesizing process of podophyllotoxin phosphonate derivate Expired - Fee Related CN100410266C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100111495A CN100410266C (en) 2006-01-11 2006-01-11 Synthesizing process of podophyllotoxin phosphonate derivate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100111495A CN100410266C (en) 2006-01-11 2006-01-11 Synthesizing process of podophyllotoxin phosphonate derivate

Publications (2)

Publication Number Publication Date
CN100999534A CN100999534A (en) 2007-07-18
CN100410266C true CN100410266C (en) 2008-08-13

Family

ID=38258367

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100111495A Expired - Fee Related CN100410266C (en) 2006-01-11 2006-01-11 Synthesizing process of podophyllotoxin phosphonate derivate

Country Status (1)

Country Link
CN (1) CN100410266C (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2207674A (en) * 1987-08-04 1989-02-08 Bristol Myers Co Podophyllotoxin derivatives
CN1013232B (en) * 1986-10-17 1991-07-17 通用电气公司 Laminar flow gun for light valves
CN1129499A (en) * 1993-06-17 1996-08-21 斯凯德特公司 Frame relay protocol-based multiplex switching scheme for satellite mesh network

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1013232B (en) * 1986-10-17 1991-07-17 通用电气公司 Laminar flow gun for light valves
GB2207674A (en) * 1987-08-04 1989-02-08 Bristol Myers Co Podophyllotoxin derivatives
CN1129499A (en) * 1993-06-17 1996-08-21 斯凯德特公司 Frame relay protocol-based multiplex switching scheme for satellite mesh network

Also Published As

Publication number Publication date
CN100999534A (en) 2007-07-18

Similar Documents

Publication Publication Date Title
CN108424388B (en) Preparation method of medicine for treating chronic anemia
EP3712130B1 (en) Method for synthesis of roxadustat and intermediate compounds thereof
CN107235923B (en) Preparation method of 3-aryl quinoxalinone derivatives
CN102584795A (en) Preparing method of crizotinib
CN103232369B (en) Preparation method of fmoc chloride glutamic acid-5-tert-butyl ester
CN104987333A (en) Filgotinib synthetic method
CN100410266C (en) Synthesizing process of podophyllotoxin phosphonate derivate
CN101560191A (en) Alpha-menaphthyl substituted spiro bis(oxazoline) ligands, synthetic method and application thereof in synthesizing pyrazolidine derivatives
CN109824725A (en) A kind of preparation method of 4- phosphate -2H- chromene derivative
CN111548356B (en) Process for preparing tert-butyl-1, 8-dioxa-4, 11-diazaspiro [5.6] dodecane-11-carboxylic acid ester
CN112300019A (en) Preparation method of o-acetamidophenylbutyric acid compound
CN102786543B (en) The preparation method of imidazo [1,2-a] pyridine-6-pinacol borate and derivative thereof
CN112939814B (en) Preparation method of deuterated dacarbazine intermediate
CN112679430B (en) Method for preparing isoquinolinones compound
CN102786541A (en) Preparation method and application of potassium (iso)quinoline thifluoroborate
CN106243079A (en) The Preparation Method And Their Intermediate compound of bicyclol
US8076480B2 (en) Process of preparing optically active allyl compound
CN101239998A (en) Method of synthesizing 1,2,3-tri-acetyl-5-deoxy-D-ribose
CN114213483B (en) Preparation method of marine flavone glycoside
CN112679429B (en) Method for preparing isoquinolinones compound
CN113773294B (en) Preparation method and application of flavone and isoflavone compounds
AU2433099A (en) Glycosidation of 4,5-epoxymorphinan-6-ols
CN113480453B (en) Synthesis method of NH2-PEG5-NHBoc
CN112979695B (en) Method for preparing 1, 2-di-fatty acyl-sn-glycerol-3-phosphatidylserine
CN114478373B (en) Preparation method of sulfamate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: CHONGQING HUAPONT PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: HUABANG PHARMACEUTICAL CO., LTD., CHONGQING

Effective date: 20130217

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 400041 JIULONGPO, CHONGQING TO: 401121 YUBEI, CHONGQING

TR01 Transfer of patent right

Effective date of registration: 20130217

Address after: 401121 Chongqing, Yubei District and the number of stars Avenue, No. 69

Patentee after: Chongqing Huapont Pharm. Co., Ltd.

Address before: Jiulongpo District from the South Garden, park four street 400041 Chongqing City No. 55

Patentee before: Huabang Pharmaceutical Co., Ltd., Chongqing

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080813

Termination date: 20200111

CF01 Termination of patent right due to non-payment of annual fee